Drugs / ITF2984
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01897844 | May → Sep 2013 | — | Italfarmaco | Completed | No outcome recorded |
| Phase 1 | NCT01871844 | Jan → Sep 2012 | — | Italfarmaco | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02111044 | Apr 2014 → Feb 2016 | acromegaly | Italfarmaco | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ITF2984 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01897844 ↗ |
| Modality | Other / unclassified | “ITF2984 (somatostatin analogue)” NCT01871844 ↗ |
| Route | Subcutaneous | “ITF2984 500 mcg/Placebo sc bid for 7 days” NCT01871844 ↗ |